That stock News

Dechra Pharmaceuticals
p 528-11, 5 p
Questor says BUY

At the end of last week, listed in London Dechra Pharmaceuticals announced the acquisition of the US group DermaPet.Il resembles a move cunning group of veterinary products.

Not only it make some important new products in the enterprise, but it the shores of the Group us sales team thus, closer to mass critical operations across the pond.DermaPet develops and markets a range of dermatological products for animals, such as shampoos, conditioners and ear.

The maximum payment for company is $ 64 million (￡ 40 4 m), with 42 million money right from the start. The rest of the counterparty is a deferred payment - and depends on respected revenue objectives.

Payments for 1 m $ are due on the second and the fourth anniversaries of the date of completion, with 15 m $ becomes payable between the second and sixth birthdays completion should DermaPet realizes income of more than 15 m $ for a rolling 12-month period after the first anniversary of the fin.Si income of the same criteria exceed 20 m $, another $5 m will become due.

For the six months to June 30, DermaPet revenue was $6.9 m and taxes profit a 3 m $.

To finance the purchase, Dechra has agreed a new ￡ 78 m four - year Bank facility to replace facilities actuelles.Dette at the end of June stood at only ￡ 6.7 m, the balance sheet is strong enough to be able to cope with a transaction of this size.

DermaPet was created in 1991 by American Dr. Steve Melman, who appeared on US television regularly and is the author of several well received books on veterinary care.This transaction represents the output of an undertaking, which he spent the better part of the construction of the last two decades.

The company expects that the purchase will be "sensitive" win improvement in its first full year of the property.

Questor recommended actions about one year there is reason the Dechra moving towards United States where companion animals market is significantly greater is the United Kingdom.

United Kingdom, there are 8 m of dogs, cats 8.4 m and 1 m.Aux United States horses he has even more - 75 m dogs, cats 82 m and 10 m horses '.the acquisition has accelerated the process of tapping this vast market and, although not without execution risk, is a sound strategic move.

Purchase brings a number of interesting products in the groupe.Ceux note is TrizUltra antifungal treatment and antibacterial skin DermaLyte, a shampoo for bathing and MalAcetic, allergic pets for cleaning of infected animals ears.

Dechra will also acquire a five additional sales representatives and it is expected that approximately 1 m $ synergies can be extracted from the two opérations.Co?ts restructuring are expected to be of the order of 1 m $.

Actions had lower market since their initial recommendation, as Quaestor indicated in the last update on September 9, but they began to perform after the news of this strategic acquisition.

Shares are trading on June 2011 multiple 16.1 times earnings falling to 14.3 2012.Les actions are 2 1pc.

Shares were initially recommended October 25 year p 427.9 last and they are now 23pc 8pc.La market versus rating on the shares still buy.

View the original article here